Melatonin Teva (Melatonin)

Melatonin binds to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus, the master clock that regulates circadian rhythms. This receptor activation signals the body that it is nighttime, promoting physiological changes such as a drop in core body temperature and the onset of sleep.

The appropriate dose of Melatonin Teva is determined by the prescribing clinician based on the individual’s age, condition, and response to therapy. Patients should follow the prescriber’s instructions and not alter the dose without medical guidance.

Safety data for melatonin use in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with prescription hypnotics such as benzodiazepines, melatonin has a different mechanism focused on circadian regulation rather than direct central nervous system depression, often resulting in a more favorable side‑effect profile. Over‑the‑counter melatonin products may vary in dose and purity, whereas Melatonin Teva is supplied as a regulated pharmaceutical grade product.

Melatonin Teva should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Melatonin Teva is taken orally, usually with a glass of water. It is commonly administered 30–60 minutes before the desired bedtime to align with the body’s natural sleep onset period. Patients should follow the timing instructions provided by their prescriber.

Serious but rare risks include severe allergic reactions (rash, swelling, difficulty breathing), mood disturbances such as depression or anxiety, seizures, and abnormal heart rhythms. Any of these symptoms should prompt immediate medical evaluation.

Individuals with known hypersensitivity to melatonin or any excipients in the formulation should avoid use. Caution is also advised for patients with uncontrolled hepatic disease, severe depression, or those taking medications that have major interactions listed above. A healthcare professional should evaluate suitability before initiating therapy.